SHC
Sotera Health Co
NASDAQ · Life Sciences Tools & Services
$17.75
+0.35 (+2.01%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.10B | 1.04B | 1.75B | 1.54B | 1.43B |
| Net Income | 44.26M | 37.68M | 192.59M | 136.55M | 122.70M |
| EPS | — | — | — | — | — |
| Profit Margin | 4.0% | 3.8% | 11.0% | 8.9% | 8.6% |
| Rev Growth | +5.7% | +5.7% | -5.5% | -8.4% | -6.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.15B | 2.15B | 867.73M | 855.12M | 816.04M |
| Total Equity | 374.51M | 374.51M | 3.71B | 3.46B | 4.04B |
| D/E Ratio | 5.73 | 5.73 | 0.23 | 0.25 | 0.20 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 339.83M | 305.40M | 263.62M | 244.92M | 215.08M |
| Free Cash Flow | — | — | 165.32M | 111.36M | 136.21M |